Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to January 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $961.0M |
| Sales growthchange from the year before | +24.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 70.1% |
| Operating marginshare of sales left after running the business | -17.6% |
| Net marginshare of sales kept as profit | -16.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | 11.0% |
| Return on invested capitalprofit made on each $100 put into the business | -8.8% |
| Return on equityprofit vs. shareholders' accounting value | -10.5% |
| Debt / equitydebt vs. shareholders' accounting value | 0.00 |
| Change in share countnegative = the company is buying back its shares | +119.2% |
1 insider sold $7.5M (all under pre-arranged plans) on the open market.
| Mahdessian AraChief Executive Officer · Director | Sold (plan)Aug 4 | 38,287 shat $84.89 · $3.3M |
| Mahdessian AraChief Executive Officer · Director | Sold (plan)Aug 3 | 49,766 shat $84.75 · $4.2M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy